gardasil (Merck & Co)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Merck & Co gardasil
Gardasil, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gardasil/gardasil/pmc13065502-85-0-11
Average 86 stars, based on 1 article reviews

gardasil - by Bioz Stars, 2026-11

86/100 stars

Images

Vaccines:

Article Title: Therapeutic potential of fucoidan in cervical cancer as a modulatory adjuvant: In vivo and in vitro study
Article Snippet: .. While the development and widespread adoption of vaccines, such as Gardasil (Merck), have significantly reduced the incidence of cervical cancer in developed countries, high cervical cancer incidence and mortality rates persist in developing countries, where vaccine distribution remains limited[3]. ..

Article Title: Cervical Cancer in Women With HIV: A Call to Action for Equitable Prevention in Low‐ and Middle‐Income Countries
Article Snippet: .. Gardasil (Merck & Co., Kenilworth, New Jersey) [ ] and Cervarix (GlaxoSmithKline, Rixensart, Belgium) were the first US FDA‐approved HPV vaccines for hrHPV [ ]. ..

Article Title: Cancer Vaccines: Mobilizing Immunity for Targeted Cancer Therapy
Article Snippet: .. Currently, two major HPV vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline), have been developed to target high-risk HPV types, particularly HPV16 and HPV18, which are responsible for approximately 70% of cervical cancer cases. ..

other:

Article Title: Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination
Article Snippet: Risk of bias summary: CIN2+ (Continued) CIN2+: cervical intraepithelial neoplasia grade 2 or higher Study Vaccine Population (sex, age at vaccination) Sample size Effect measure (time period) Effect estimate Adjustment factors Notes Donken 2021- CAN Gardasil (Merck quadrivalent) Female, 9 to 14 years Vaccinated: 18,975 Unvaccinated: 14,130 Incidence rate ratio (long-term) 0.59 (0.40 to 0.88) Birth year, age at first screening Cohort Palmer 2019- GBR Cervarix (GSK bivalent) Female, 12 to 13 years NR Odds ratio (3 doses; long-term) 0.11 (0.06 to 0.19) Deprivation, rurality Cohort Palmer 2019- GBR Cervarix (GSK bivalent) Female, 12 to 18+ years NR Odds ratio (2 doses; long-term) 0.70 (0.45 to 1.07) Deprivation, rurality Cohort Cochrane Library Trusted evidence.

Recombinant:

Article Title: Biopharmaceuticals for Cancer Treatment: An Update
Article Snippet: Provenge/ Sipuleucel‐T , April 29, 2010/ Dendreon Pharmaceuticals LLC , Prostate‐specific antigen (PSA) targeting autologous cellular immunotherapy , Cellular immunotherapy , Prostate cancer , Intravenous/ N/A N/A , N/A , [ ] . .. Gardasil, Gardasil 9, Cervarix/ Human Papillomavirus vaccine , June 8, 2006/ Merck Sharp & Dohme LLC , A recombinant Human Papillomavirus Quadrivalent (Types 6, 9, 11, 16, and 18) vaccine , Vaccine , Cervical, vaginal, vulvar and anal cancer caused by HPV , Intramuscular/ N/A N/A , N/A , [ ] . .. Anktiva/Nogapendekin alfa inbakicept‐pmln , April 22, 2024/ Altor BioScience LLC, an indirect wholly owned subsidiary of ImmunityBio Inc.v , An interleukin‐15 (IL‐15) receptor agonist used with combination of Bacillus Calmette‐Guérin (BCG) , BCG‐unresponsive non‐muscle invasive bladder cancer , Intravesical/ N/A N/A , N/A , [ ] .

Review

gardasil (Merck & Co)

Structured Review

Images

Related Articles

Vaccines:

other:

Recombinant:

Similar Products

Image Search Results